Law360, New York (May 2, 2012, 7:04 PM EDT) -- Matthew B. McFarlane, an associate in the New York office of Robins Kaplan Miller & Ciresi LLP, concentrates his practice in life sciences and Hatch-Waxman intellectual property litigation relating to technology including medical and biological sciences, biotechnology, pharmaceuticals and chemicals. He has a Ph.D. in molecular and cellular physiology from Stanford University School of Medicine.
Q: What is the most challenging case you have worked on and what made it challenging?
A: The most challenging case I have been involved with was defending Hoffmann-La Roche and...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.